These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3912933)

  • 21. [HLA antigens in blood donors, asymptomatic chronic carriers of the viral hepatitis type B surface antigen (HBsAg)].
    Morales VH; Barbetti A; Basualdo JA; Jmelnitzky A; Landoni N; Ponce de León H; Chopita N; de Torres RA
    Medicina (B Aires); 1983; 43(2):175-80. PubMed ID: 6664285
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term observation of HBsAg positive patients and carriers (author's transl)].
    Wu BP
    Zhonghua Yu Fang Yi Xue Za Zhi; 1981 Jul; 15(4):245-7. PubMed ID: 7333195
    [No Abstract]   [Full Text] [Related]  

  • 23. [A follow-up study on HBsAg carriers and factors affecting negative-conversion].
    Hong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome of renal transplantation in hepatitis BsAg-positive patients.
    Nelson SR; Snowden SA; Sutherland S; Smith HM; Parsons V; Bewick M
    Nephrol Dial Transplant; 1994; 9(9):1320-3. PubMed ID: 7816299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Liver transplantation in HBsAg-positive patients: does preventive immune treatment improve prognosis?].
    Erhard J; Layer P
    Z Gastroenterol; 1993 Apr; 31(4):267-8. PubMed ID: 8493809
    [No Abstract]   [Full Text] [Related]  

  • 26. [Importance of the immune system in the symptom-free HBsAg carrier state].
    Mansurov KhKh; Asfandiiarova NS
    Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
    [No Abstract]   [Full Text] [Related]  

  • 27. [The incidence of hepatitis B and HBsAg carrier state in families caused by (nonparenteral) contact].
    Horejsí J; Cerhová M; Jezková Z; Májský A; Mimra J; Novák J; Svorcová V
    Vnitr Lek; 1980 Apr; 26(4):234-41. PubMed ID: 7385610
    [No Abstract]   [Full Text] [Related]  

  • 28. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epidemiological significance, clinico-morphological evaluation and behavior of pathogenetic factors, in asymptomatic chronic carriers of the HBsAg in the La Plata area. Study in voluntary blood donors].
    Jmelnitzky A; Basualdo JA; Landoni N; Ponce de León H; Morales V; Chopita N; Doria I; Fink N; Barbetti A; Castelletto R; Veron M; de Torre R
    Acta Gastroenterol Latinoam; 1982; 12(2):117-34. PubMed ID: 7158240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hepatitis virus markers in a group of homosexuals].
    Puelma E; Velasco M
    Rev Med Chil; 1982 Dec; 110(12):1176-8. PubMed ID: 7184104
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prevention of viral hepatitis B in exposure to carriers of HBsAG in Plzen in 1998].
    Pazdiora P; Petríková V; Fránová D
    Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):153-9. PubMed ID: 10658343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers].
    Löschner J; Fengler JD; Baumgarten R
    Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection of delta, core and surface antigens in the liver of chronic HBsAg carriers.
    Picciotto A; Bastardini R; Boscarino S; Lapertosa G; Mansi C; Savarino V; Celle G
    Pathologica; 1983; 75(1035):121-5. PubMed ID: 6348677
    [No Abstract]   [Full Text] [Related]  

  • 34. Fulminant hepatic failure in a renal transplant recipient with positive hepatitis B surface antigens: a case report of fibrosing cholestatic hepatitis.
    Hung YB; Liang JT; Chu JS; Chen KM; Lee CS
    Hepatogastroenterology; 1995; 42(6):913-8. PubMed ID: 8847045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between ADCC effector cells and the combination therapy of pantethine and lecithin--a proposal for management of patients with HBsAg carrier state (author's transl)].
    Murata T; Oniki H; Kimura Y; Komoda T; Yamashita Y; Nakamura S; Koga Y
    Igaku Kenkyu; 1981 Oct; 51(4):213-23. PubMed ID: 7331739
    [No Abstract]   [Full Text] [Related]  

  • 36. HBV and HCV infection in kidney transplant recipients.
    Frider B; Castaño G; Sookoian S; Livellara B; Kina M; Sabatiello R; Castiglione T; Iotti R; Vázquez MC
    Acta Gastroenterol Latinoam; 1993; 23(2):75-81. PubMed ID: 8249531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E; Brunet Mdel R; Cusumano A; Diaz C; Michel MD; Jost L; Jost L; Mando OG; Vilches A
    Medicina (B Aires); 2004; 64(5):429-32. PubMed ID: 15560544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Delta infection in HBsAg carriers].
    Hess G; Slusarczyk J; Hansson BG; Dienes HP; Baumann W; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1984 Dec; 22(12):692-6. PubMed ID: 6396986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preemptive lamivudine therapy based on HBV DNA level in HBsAg-positive kidney allograft recipients.
    Chan TM; Fang GX; Tang CS; Cheng IK; Lai KN; Ho SK
    Hepatology; 2002 Nov; 36(5):1246-52. PubMed ID: 12395336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.